Active traders and day traders have many stocks to choose from this morning.  We are tracking moves in Celldex Therapeutics, Inc. (NASDAQ: CLDX), Gymboree Corp. (NASDAQ: GYMB), Geron Corporation (NASDAQ: GERN), MEMC Electronic Materials Inc. (NYSE: WFR), MaxLinear, Inc. (NYSE: MXL), SIRIUS XM Radio Inc. (NASDAQ: SIRI), and The Talbots, Inc. (NYSE: TLB).

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is trading up 14% to $4.47 versus a 52-week range of $2.91 to $9.49 after reports that its brain cancer vaccine doubled the survival rates.  Shares were up over 20% last night and it traded over 200,000 shares after Monday’s closing bell.

Gymboree Corp. (NASDAQ: GYMB) is up 4.7% at $50.50 after hiring Goldman Sachs to find a buyer.  Keep in mind this rose 20% initially on the news Friday.

Geron Corporation (NASDAQ: GERN) is trading up ahead of a Stem Cell conference presentation and on the launch of GE Healthcare’s human cardiomyocyte product for drug discovery and toxicity screening.  Shares are up 4% at $5.38.

MEMC Electronic Materials Inc. (NYSE: WFR) is rising by about 5.6% at $12.42 after the company’s SunEdison unit announced the sale of PV factory in Italy for about $378 million.

MaxLinear, Inc. (NYSE: MXL) is trading down about 15.5% at $9.60, a 52-week low under the prior year range of $9.65 to $19.50, on news that it lowered his third quarter guidance.

SIRIUS XM Radio Inc. (NYSE: SIRI) is up again this morning with a gain of under 1% but at $1.28 which matches the 52-week high put in yesterday.  As noted at VSInvestor.com late yesterday, stock options trading is elevated and that is odd for a $1.00 stock.

The Talbots, Inc. (NYSE: TLB) is getting clipped after mixed guidance for he quarter and after setting targets out to2014.  Shares are down 10.6% at $11.21.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.